Stay updated with breaking news from Regor Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- DelveInsight's Type 2 Diabetes Market Insights report includes a comprehensive understanding of current treatment practices, type 2 diabetes...
On April 6, 2023, AbbVie announced that it was voluntarily withdrawing ibrutinib, which was granted accelerated approval for two indications: mantle...
On April 6, 2023, AbbVie announced that it was voluntarily withdrawing ibrutinib, which was granted accelerated approval for two indications: mantle...
In January 2023, the FDA issued a new draft guidance document on optimizing the dosage of drugs and biological products for the treatment of...
First launched in Feb. 2018 by the FDA’s Oncology Center of Excellence, the Real-Time Oncology Review (RTOR) program is intended to streamline...